Rep. Alexandria Ocasio-Cortez is again pushing for legislation that would remove federal barriers to research the therapeutic potential of psychedelic substances like MDMA, psilocybin and ibogaine.
While a number of private institutions and universities are currently researching the therapeutic potential of a host of psychedelic molecules, most of these remain classified as Schedule I drugs.
Currently, a rider on a 1996 spending bill bans the allocation of federal funds to “any activity that promotes the legalization of any drug or other substance in Schedule I.”
Ocasio-Cortez’s measure was introduced as an amendment to a broader spending bill that covers fund allocation for multiple federal agencies. The amendment would strike the rider, thus making research into psychedelics possible for federal agencies.
“It is ridiculous that Congress upholds War on Drugs-era barriers on federal research into substances like psilocybin, ibogaine, & MDMA when early results are indicating major promise in treating PTSD, addiction, & more.
I’m trying (again) to lift them so we can pursue the science,” said the Congresswoman in a tweet.
Ocasio-Cortez has introduced a similar amendment in the 2019 congressional session, though it was broadly rejected by members of both parties.
“Last time I intro’d this, both parties voted against it & some laughed,” the representative said on Twitter. “But I am undeterred! I’ll keep bringing it up until the times catch up.”
Picture by Kalineri on Unsplash And Wikimedia Commons
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.